cnj-016
Generic: Vaccinia Immune Globulin Intravenous (Human)·Code: VIGIV
cnj-016: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Emergent BioSolutions Inc. (EBS) | Approved |
Get deeper analysis on cnj-016
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis